Hoppenot Herve
CIK 0001596492
Special Advisor to the CEODirector
Filings
18
Latest Jan 6, 2026
Issuers covered
3
Showing
18 of 18
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +10.2% | +10.2% | +10.2% | +10.2% |
| 90 days | 1 | 0% | -2.9% | -2.9% | -2.9% | -2.9% |
| 180 days | 1 | 100% | +5.3% | +5.3% | +5.3% | +5.3% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Hoppenot Herve has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INCY | Incyte Corp | 15 | Dec 10, 2025 |
| BCYC | Bicycle Therapeutics PLC | 2 | Jan 6, 2026 |
| MAZE | Maze Therapeutics, Inc. | 1 | Oct 7, 2025 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|